Form 4 for CRH CRH plc

Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0000950170-25-032035 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2025-03-04	2025-02-28	CRH	Manifold Albert Jude	See Remarks	S - Sale	$100.82	-7,000	80.1K	-8%	-$705.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2025-02-28	S	D	7,000	$100.82	80,083	D	—	—	(F1) The Reporting Person's sale of Ordinary Shares reported in this Form 4 was matchable to non-exempt automatic dividend reinvestments that occurred in December 2024 and October 2024, respectively, and were reported on Forms 8-K on December 26, 2024 (acquiring 4.640876 Ordinary Shares at a price of $93.04 per share) and October 4, 2024 (acquiring 4.674931 Ordinary Shares at a price of $91.915920 per share), respectively (the "Dividend Reinvestments"). The Reporting Person retired from his position as Chief Executive Officer and as a member of the Board of Directors of the Issuer, effective December 31, 2024, and therefore a Form 3 was not filed in connection with the Issuer's transition to U.S. domestic issuer reporting status, effective January 1, 2025. (F2) The Reporting Person has preemptively disgorged $84.63 to the Issuer, representing the full amount of the profit realized on the differential between the above-mentioned sale and the Dividend Reinvestments. (F3) The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $100.13 and $101.56, inclusive, of shares sold on the New York Stock Exchange. Full information regarding the number of shares sold at each separate price in the range will be provided to the SEC upon request.